CLB — Stock Film
STOCK FILMSCENE 1/11CLB · $11.12
Stock Expert AI presents
CLB
Core Laboratories N.V
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Core Laboratories N.V. A quick introduction.

On the stock market since 1995, it operates in the world of energy. It has 3,300 employees. Now — the numbers.

on the stock market since 1995
3,300 employees
$512.4M market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $6 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 6%

This is an established company with proven profits.

WHERE DOES THE MONEY COME FROM?
76%Services
Services 76%Products 24%
76% of all revenue comes from a single line: Services.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

THE SALES TREND
Sales are moving sideways.

No real growth (3% a year).

$470.3M
2021
$489.7M
2022
$509.8M
2023
$523.8M
2024
$526.5M
2025
Cash on hand:
$0
Total debt:
$0
The debt outweighs the cash.

The gap is $141.3M. In times of high interest rates, a gap like that can squeeze a company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
57
average

Profit indicators sit around the sector average.

FINANCIAL STRENGTH
66
strong

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
59
average

The price isn’t cheap next to earnings — that’s why this grade sits in the middle.

GROWTH
55
average

There is growth, but not at top-of-the-class tempo.

PRICE MOMENTUM
12
very weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 68% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Analysts’ target sits above today’s price

The average analyst price target is $25.00125% above today’s price.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $0.04 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
Growth has stalled

Over the last 3 years, sales grew only 2% a year on average. At this size, speeding back up is not easy.

2
THE RISKS · 2/2
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 12/100. For a turnaround signal, the stock first needs to close the gap with the market.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, CLB sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: CLB is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.

Analysts’ average target sits above today’s price, yet the valuation grade (59/100) says the stock isn’t cheap.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film